In the world of pharmaceuticals, companies aim to operate under GMP guidelines — a set of production and manufacturing measures to assure standards for medicinal products. But too often ...

I write about business model strategy and execution across healthcare. Pharmaceutical executives are waking up to a hard new reality. The winds of healthcare economic change, accelerated by a ...

Pharmaceutical sales are expected to grow 6.2% per year through 2028. Pharma stocks are good defensive investments. Some pay sizable dividends that can help offset the impact of inflation. The ...

That suggests Big Pharma groups should be ploughing resources into a vaccine arsenal to tackle the next big virus. Yet right now they’re not, and it’s far from clear that they will.

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Now showing summary data for the 2024 election cycle. Now showing data for the election cycle. The pharmaceutical and health products industry — including not only drug manufacturers but also dealers ...

Divi’s Laboratories Limited specialises in producing active pharmaceutical ingredients and intermediates. The company is engaged in the manufacturing and custom synthesis of generic APIs and ...

NEW YORK, Sept 5 (Reuters) - Purdue Pharma on Thursday received an 18-day extension of a years-long pause on litigation against its owners, members of the wealthy Sackler family, after convincing ...

Terns Pharmaceuticals Inc.’s stock soared 17% Monday after the company said an early stage trial of its obesity treatment in pill form achieved statistically significant weight loss of up to 5.5 ...

Kairos Pharma, Ltd KAPA IPO will take place September, 12 on the NASDAQ exchange under the ticker KAPA. The company is offering shares at an expected price of $4.00 per share with an insider lock ...

A good imagination and persistence are required. Medicinal and pharmaceutical chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the ...

Scott Wiener of San Francisco, a Democrat, would require PBMs to apply for a license by 2027 and would mandate that licensed PBMs pass along 100% of pharmaceutical manufacturers’ rebates to ...